These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2590547)

  • 1. Comparative study of proportion of S-phase cells in ascites and pleural effusions in ovarian carcinoma using antibromodeoxyuridine monoclonal antibody and DNA flow-cytometry.
    Sahni K; Tribukait B; Einhorn N
    Acta Oncol; 1989; 28(5):705-8. PubMed ID: 2590547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of nucleolar organiser regions and DNA flow cytometry in the evaluation of pleural effusion.
    Huang MS; Tsai MS; Hwang JJ; Wang TH
    Thorax; 1994 Nov; 49(11):1152-6. PubMed ID: 7831633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric measurement of ploidy and proliferation in effusions of ovarian carcinoma and their possible prognostic significance.
    Sahni K; Tribukait B; Einhorn N
    Gynecol Oncol; 1989 Nov; 35(2):240-5. PubMed ID: 2807018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of ploidy and cell proliferation in serial samples of ascites from patients with ovarian carcinoma.
    Sahni K; Tribukait B; Einhorn N
    Acta Oncol; 1990; 29(2):193-7. PubMed ID: 2334572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokinetic investigation of lung tumors using the anti-bromodeoxyuridine (BUdR) monoclonal antibody method: comparison with DNA flow cytometric data.
    Teodori L; Trinca ML; Goehde W; Hemmer J; Salvati F; Storniello G; Mauro F
    Int J Cancer; 1990 Jun; 45(6):995-1001. PubMed ID: 2161804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of ascites from patients with ovarian carcinoma by cell flow cytometry.
    Rotmensch J; Atcher RW; Schwartz JL; Grdina DJ
    Gynecol Oncol; 1992 Jan; 44(1):10-2. PubMed ID: 1730415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid detection of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in 9L brain tumor cells in vitro and in situ.
    Nagashima T; Hoshino T
    Acta Neuropathol; 1985; 66(1):12-7. PubMed ID: 3993331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interphase nucleolar organizer regions in the evaluation of serosal cavity effusions.
    Carrillo R; Sneige N; el-Naggar AK
    Acta Cytol; 1994; 38(3):367-72. PubMed ID: 8191825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric analysis of DNA content in human ovarian cancers.
    Erba E; Ubezio P; Pepe S; Vaghi M; Marsoni S; Torri W; Mangioni C; Landoni F; D'Incalci M
    Br J Cancer; 1989 Jul; 60(1):45-50. PubMed ID: 2803914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cell kinetic analysis of human brain tumors by bivariate flow cytometric measurement of cellular DNA content and amount of incorporated bromodeoxyuridine].
    Okuda Y; Taomoto K; Saya H; Ijichi A; Kudo H; Kokunai T; Tamaki N; Matsumoto S
    No To Shinkei; 1989 Apr; 41(4):383-90. PubMed ID: 2765301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between DNA content, expression of Ki-67 antigen of tumor cells and immunophenotype of lymphocytes from malignant pleural effusions.
    Sikora J; Dworacki G; Trybus M; Batura-Gabryel H; Zeromski J
    Tumour Biol; 1998; 19(3):196-204. PubMed ID: 9591046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In-vivo marking of human tumors using BUDR for flow-cytometry determination of kinetic cell parameters].
    Kärcher H; McNally NJ; Wilson G; Kärcher KH; Pfragner R
    Strahlenther Onkol; 1987 Mar; 163(3):195-200. PubMed ID: 3563881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bromodeoxyuridine incorporation into DNA of human leukemia cells is not concentration dependent.
    Powell BL; Gregory BW; Kute TE; Morgan TM; Lyerly ES; Capizzi RL
    Cytometry; 1990; 11(3):438-41. PubMed ID: 2340778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of S-phase fraction and DNA ploidy studied with in vivo administration of bromodeoxyuridine on human gastric cancers.
    Ohyama S; Yonemura Y; Miyazaki I
    Cancer; 1990 Jan; 65(1):116-21. PubMed ID: 2293858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric identification of cancer cells in effusions with Ca1 monoclonal antibody.
    Czerniak B; Papenhausen PR; Herz F; Koss LG
    Cancer; 1985 Jun; 55(12):2783-8. PubMed ID: 3888371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferative characteristics of primary and metastatic human solid tumors by DNA flow cytometry.
    Frankfurt OS; Greco WR; Slocum HK; Arbuck SG; Gamarra M; Pavelic ZP; Rustum YM
    Cytometry; 1984 Nov; 5(6):629-35. PubMed ID: 6518938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA index of ovarian carcinomas from 56 patients: in vivo in vitro studies.
    Erba E; Vaghi M; Pepe S; Amato G; Bistolfi M; Ubezio P; Mangioni C; Landoni F; Morasca L
    Br J Cancer; 1985 Oct; 52(4):565-73. PubMed ID: 4063134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive effusion cytology as the initial presentation of malignancy.
    Monte SA; Ehya H; Lang WR
    Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new epithelial membrane antigen (Calam 27) as a marker of carcinoma in serous effusions.
    Gioanni J; Caldani C; Zanghellini E; Mazeau C; Duplay H; Ferrua B; Schneider M
    Acta Cytol; 1991; 35(3):315-9. PubMed ID: 2042433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometry as a tool for the prognostic assessment of human neoplasia.
    Mauro F; Teodori L; Schumann J; Göhde W
    Int J Radiat Oncol Biol Phys; 1986 Apr; 12(4):625-36. PubMed ID: 3700167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.